TIDMOPTI

RNS Number : 8611Z

OptiBiotix Health PLC

27 January 2022

OptiBiotix Health plc

("OptiBiotix" or the "Company")

Exercise of Warrants

OptiBi otix Health p lc (AI M : OPTI), a life sciences busi ness d e vel o ping co m p o u n ds to tack le o besit y, high choleste r ol, diabetes and skincare, announces that it has received notification to exercise warrants over 125,000 new ordinary shares of 2p each in the capital of the Company ("Ordinary Shares"). The exercise price of the warrants was 8p per share. The current issued share capital for Optibiotix Health plc is 87,940,601 ordinary shares of 2p.

Application will be made for the 125,000 new Ordinary Shares to be admitted to trading on AIM, which is expected to occur at 8.00 a.m. on or around 2 February 2022. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares.

Total Voting Rights

For the purpose of the Disclosure and Transparency Rules, following the issue of shares detailed above the enlarged issued share capital of the Company will comprise 88,065,601 ordinary shares of 2p each. The Company does not hold any ordinary shares in treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

For further information, please contact:

 
 OptiBiotix Health plc                              www.optibiotix.com 
 Stephen O'Hara, Chief Executive                  Contact via Walbrook 
                                                                 below 
 
 
 Cairn Financial Advisers LLP (NOMAD)               Tel: 020 7213 0880 
  Liam Murray / Jo Turner / Ludovico Lazzaretti 
 
 Cenkos Securities plc (Broker)                     Tel: 020 7397 8900 
 Callum Davidson / Neil McDonald 
 Michael Johnson / Russell Kerr (Sales) 
 
 Walbrook PR Ltd                                    Mob: 07876 741 001 
 Anna Dunphy

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEFZGZMGNKGZZM

(END) Dow Jones Newswires

January 27, 2022 05:38 ET (10:38 GMT)

OptiBiotix Health (AQSE:OPTI.GB)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas OptiBiotix Health.
OptiBiotix Health (AQSE:OPTI.GB)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas OptiBiotix Health.